NextGen-O2k Exploitation: Difference between revisions
From Bioblast
Laner Verena (talk | contribs) (Created page with "{{Template:NextGen-O2k header page name}} {{MitoFit highlights page name}} :::: <big><big>The revolutionary all-in-one instrument to conquer mitochondrial disease. </big></big...") |
Laner Verena (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
{{MitoFit highlights page name}} | {{MitoFit highlights page name}} | ||
{{Template:NextGen-O2k header page name logo}} | |||
:::: <big><big>The revolutionary all-in-one instrument to conquer mitochondrial disease. </big></big> | :::: <big><big>The revolutionary all-in-one instrument to conquer mitochondrial disease. </big></big> | ||
<br /> | <br /> | ||
Line 6: | Line 6: | ||
<br /> | <br /> | ||
<big><big><big>'''WP4 | <big><big><big>'''WP4: Exploitation '''</big></big></big> | ||
__TOC__ | __TOC__ |
Revision as of 14:37, 31 July 2019
Template:MitoFit highlights page name
The revolutionary all-in-one instrument to conquer mitochondrial disease.
- The revolutionary all-in-one instrument to conquer mitochondrial disease.
WP4: Exploitation
Abstract
- Prepare NextGen-O2k for a successful market launch including: (1) Preparation & execution of the IPR protection plan, (2) Preparation and implementation of certifications, (3) Partner engagement and (4)
Long-term business strategy for NextGen-O2k as a medical device and as a tool for algal biotechnology.